Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-38.68% - - 1L
+0.94%+2.40%+3.27%+11.24% 5.04TCr
+0.72%+1.00%+396.18%+624.25% 4.06TCr
+2.54%+0.93%+28.98%-3.62% 3.49TCr
+0.31%+1.74%+18.44%+59.76% 3.37TCr
-2.09%-1.98%+3.21%+33.56% 2.63TCr
-0.63%+0.34% - - 1.71TCr
+0.66%-3.96%+66.85%+127.36% 1.53TCr
-23.90%-21.43%+50.06%+53.83% 1.06TCr
+1.31%+0.43%+14.91%+22.34% 1.37TCr
Average -2.02%-2.71%+72.74%+116.09% 2.7TCr
Weighted average by Cap. -0.48%-0.61%+87.50%+139.77%

Financials

2020 2021
Net sales 15.02L 17.17L 13.85L 12.82L 24.33L 16Cr 24.74L 1.66Cr 65.04L 8.05Cr 64.47L 63.07L 28Cr 10.77L 12.31L 10L 9L 17.44L 12Cr 17.74L 1.19Cr 46.63L 5.77Cr 46.22L 45.22L 20Cr
Net income 1.47Cr 1.69Cr 1.36Cr 1.26Cr 2.39Cr 160.91Cr 2.43Cr 16Cr 6.38Cr 79Cr 6.33Cr 6.19Cr 273.7Cr -1.06Cr -1.21Cr -97.51L -90.22L -1.71Cr -115.38Cr -1.74Cr -12Cr -4.58Cr -57Cr -4.54Cr -4.44Cr -196.26Cr
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33